The Globe and Mail reports in its Thursday, Nov. 30, edition that Acumen Capital analyst Jim Byrne is keeping his "buy" call on Calian Group intact. The Globe's Darcy Keith writes in the Eye On Equities column that Mr. Byrne trimmed his share target back by $2 to $75. Analysts on average target the shares at $74. Mr. Byrne says in a note: "In our view the long-term thesis for Calian remains intact as they execute their growth strategy. The company is poised to post solid quarterly results in the next few quarters, and we believe investors will be rewarded for their patience. ... In our view the long-term thesis for Calian remains intact as they execute their growth strategy. The company is poised to post solid quarterly results in the next few quarters, and we believe investors will be rewarded for their patience."